13F Data
Security · CUSIP 811033109

SCRIBE THERAPEUTICS INC

COM · institutional ownership from 13F filings

Q3 2026 is still being filed (deadline 45 days after quarter end), so holder counts are incomplete.

13F holders
12
Shares held
958.1K
Value held
$17.6M
New / sold out
12 / 0
Added / reduced
0 / 0
net +958.1K shares

13F holders by quarter

Q3 2026: 12
Q3 2026Q3 2026

Net shares bought by existing holders

Q3 2026: 958.1K
Q3 2026Q3 2026

Top holders · Q3 2026

ManagerSharesValue% of portfolio
Sanofi500,000$9.2M1.46%
GEODE CAPITAL MANAGEMENT, LLC245,412$4.5M0.00%
Menlo Ventures Management, L.P.97,690$1.8M0.75%
Sumitomo Mitsui Trust Group, Inc.74,910$1.4M0.00%
Bank of New York Mellon Corp20,396$375.4K0.00%
DEUTSCHE BANK AG\8,269$152.2K0.00%
CITIGROUP INC4,742$87.3K0.00%
TEMA ETFS LLC3,046$56.1K0.00%
STRS OHIO2,600$47.9K0.00%
Russell Investments Group, Ltd.730$13.4K0.00%
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest buyers

ManagerChangeShares changeChange %
SanofiNew+500,000–
GEODE CAPITAL MANAGEMENT, LLCNew+245,412–
Menlo Ventures Management, L.P.New+97,690–
Sumitomo Mitsui Trust Group, Inc.New+74,910–
Bank of New York Mellon CorpNew+20,396–
DEUTSCHE BANK AG\New+8,269–
CITIGROUP INCNew+4,742–
TEMA ETFS LLCNew+3,046–
STRS OHIONew+2,600–
Russell Investments Group, Ltd.New+730–
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sellers

Nothing to show.